Swiss pharma faces potential US trade investigation over drug pricing pressure

Washington’s scrutiny could disrupt Swiss pharmaceutical exports, with possible knock-on effects for global medicine pricing and broader trade relations.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.